Deals channel feed

Cy­to­ki­net­ics CEO de­fends Roy­al­ty Phar­ma deal: 'That nar­ra­tive was hi­jacked'

Last year

Ex­clu­sive: Se­nior pri­ma­ry care start­up Gath­er Health has raised $16M in a new round

Last year
Health Tech

As­traZeneca taps more Chi­na-de­rived tech with $19M can­cer deal for Nona an­ti­bod­ies

Last year
R&D

Re­NA­gade is ac­quired by RNA ri­val a year af­ter megaround-backed launch

Last year
Cell/Gene Tx

Mer­ck KGaA makes $600M bet to boost man­u­fac­tur­ing for vi­ral vec­tors

Last year
Cell/Gene Tx
Manufacturing

Bio­gen makes $1.15B buy for ARCH's HI-Bio to ex­pand im­munol­o­gy pipeline

Last year

Boehringer In­gel­heim, OSE Im­munother­a­peu­tics ex­pand part­ner­ship be­yond can­cer

Last year

Sanofi, Ope­nAI, For­ma­tion Bio an­nounce AI drug de­vel­op­ment part­ner­ship

Last year
R&D
AI

Lil­ly makes an­oth­er ra­dio­phar­ma move in col­lab­o­ra­tion with Ak­tis On­col­o­gy

Last year
Startups

Health plan start­up Cen­ti­vo ac­quires pri­ma­ry care op­er­a­tor Eden Health

Last year
Startups
Health Tech

Q&A: FTC’s top health­care en­forcer on phar­ma M&A, com­pa­ny growth and PBMs

Last year
Pharma
FDA+

Eras­ca re­vamps pipeline, lay­ing off staff as it li­cens­es can­cer drugs from Chi­na and nabs $160M

Last year
R&D

GSK plans to sell off re­main­ing stake in con­sumer spin­out Ha­le­on

Last year
Pharma

Roche was in 'ad­vanced' talks to out-li­cense its An­gel­man syn­drome drug, but po­ten­tial part­ner with­drew

Last year
R&D
Pharma

J&J makes small I&I ac­qui­si­tion to en­ter com­pet­i­tive IL-13, TSLP are­na

Last year
R&D

BeiGene looks at new part­ner­ships, with a full can­cer pipeline and grow­ing foot­print

Last year
China
Pharma

Up­dat­ed: Black­stone com­mits $300M to a for­mer Mer­ck an­ti­body for asth­ma, COPD

Last year
Financing

Ex­clu­sive: Har­vard start­up rais­es $26M, strikes three phar­ma part­ner­ships for AI an­ti­body de­sign

Last year
AI

Ab­b­Vie goes deep­er in­to neu­ro­science with col­lab­o­ra­tion worth as much as $2B

Last year
Pharma

Take­da bets $100M up­front on AC Im­mune's an­ti-amy­loid Alzheimer's vac­cine

Last year
Pharma

Sanofi buys ex-US rights to Ful­crum's Phase 3 rare neu­ro­mus­cu­lar drug

Last year
Pharma

Sanofi grabs a share of No­vavax's Covid vac­cine for $500M, eye­ing com­mer­cial­iza­tion, flu com­bi­na­tion

Last year
Pharma
Coronavirus

Af­ter FTC scruti­ny of Sanofi deal, Maze finds a new Pompe part­ner in Sh­iono­gi

Last year
R&D
Pharma

BIO CEO de­fends the or­ga­ni­za­tion's about-face on the Biose­cure Act

Last year
China
First page Previous page 15161718192021 Next page Last page
A service from the Financial Times